Rut Meseguer Naturil | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Best Researcher Award

Rut Meseguer Naturil
Health Research Institute INCLIVA, Spain

Rut Meseguer
Affiliation Health Research Institute INCLIVA
Country Spain
Documents 2
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0000-0003-4376-5997

Rut Meseguer Naturil is a researcher affiliated with the Health Research Institute INCLIVA in Spain whose documented research output includes work in immunology and translational biomedical science. The available publication record highlights research involving natural killer (NK) cell biology, immunotherapy manufacturing, and therapeutic strategies for severe infectious disease. These contributions provide a basis for consideration within the Best Researcher Award category of the International Academic Excellence Awards.

Abstract

The research record associated with Rut Meseguer Naturil encompasses biomedical investigation relevant to immune-cell biology and translational medicine. A recent publication examines how donor NKG2A/NKG2C immunophenotypes influence the GMP-compliant manufacturing potential of NK cells for adoptive immunotherapy, connecting donor characteristics with the practical development of cellular therapeutic products [1]. Earlier work addressed combined therapeutic approaches in severe-to-critical COVID-19, contributing to the broader understanding of treatment strategies for complex infectious disease [2].

Keywords

NK cells, natural killer cells, NKG2A, NKG2C, adoptive immunotherapy, GMP manufacturing, immunology, COVID-19, translational medicine, biochemistry, molecular biology.

Introduction

Natural killer cells are an important component of the human immune system and have attracted substantial interest as candidates for cellular immunotherapy. Their therapeutic development requires reproducible manufacturing processes and careful consideration of biological variability. Research examining donor immunophenotypes can therefore help clarify factors associated with NK-cell production and downstream therapeutic applications [1].

Research Profile

The documented research profile is situated within Biochemistry, Genetics and Molecular Biology and intersects with immunology and translational biomedical research. The available record identifies two documents, while citation and h-index information has not been supplied. The publications demonstrate engagement with clinically relevant questions involving immune-cell therapies and severe infectious disease.

Research Contributions

  • Investigated donor NKG2A/NKG2C immunophenotypes in relation to GMP-compliant NK-cell manufacturing for adoptive immunotherapy [1].
  • Contributed to research evaluating rationales for combined therapies in severe-to-critical COVID-19 patients [2].
  • Connected laboratory immunology with translational considerations relevant to cellular therapy and clinical treatment strategies.

Publications

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, August 2026.[1].

Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology, September 11, 2023. [2].

Research Impact

The research addresses practical and clinically relevant questions in contemporary biomedical science. Work on GMP-compliant NK-cell manufacturing is particularly relevant to the translation of immune-cell research into standardized therapeutic products, while the COVID-19 publication contributes to the evidence base surrounding combination treatment strategies [1] [2].

Award Suitability

Rut Meseguer Naturil’s documented publications provide evidence of research activity spanning immune-cell biology, cellular therapy manufacturing, and clinical immunology. The combination of methodological and translational themes is relevant to the Best Researcher Award, particularly within the stated Biochemistry, Genetics and Molecular Biology subject area. Award assessment should consider the complete research record, including independently verifiable publications, scholarly impact, innovation, and broader contributions.

Conclusion

The available record presents Rut Meseguer Naturil as a researcher contributing to biomedical topics with relevance to immunotherapy and infectious disease. The documented studies provide a scholarly basis for recognition in the Best Researcher Award category, while further evaluation of the complete publication and impact record would provide a more comprehensive assessment.

References

  1. Meseguer Naturil, R., et al. (2026). Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, 18(17), 2732.
    https://doi.org/10.3390/cancers18172732
  2. Frontiers in Immunology. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology. PMID: 37767093; PMCID: PMC10520558.
    https://doi.org/10.3389/fimmu.2023.1232472
  3. MDPI. (2026). Cancers, Volume 18, Issue 17, Article 2732. Multidisciplinary Digital Publishing Institute.
    https://www.mdpi.com/2072-6694/18/17/2732
  4. Europe PMC. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Europe PMC record, PMCID: PMC10520558.
    https://europepmc.org/article/pmc/PMC10520558
  5. ORCID. (n.d.). Rut Meseguer Naturil — ORCID record. ORCID iD: 0000-0003-4376-5997.
    https://orcid.org/0000-0003-4376-5997
  6. International Academic Excellence Awards. (n.d.). Academic Excellence Awards. Award program website.
    https://academicexcellenceawards.com/

Priya Saxena | Biochemistry | Best Researcher Award

Dr. Priya Saxena | Biochemistry | Best Researcher Award

South Dakota School of Mines and Technology, United States

Dr. Priya Saxena is a highly motivated biotechnologist pursuing her Ph.D. in Chemical and Biological Engineering at the South Dakota School of Mines and Technology (SDSM&T), with expected completion in May 2025 under the mentorship of Prof. (Dr.) Rajesh K. Sani. Her research bridges environmental microbiology, molecular biology, and computational biology, with a particular emphasis on sulfate-reducing bacteria (SRB), biofilm formation, and stress adaptation on metallic and non-metallic surfaces. She has gained expertise in anaerobic microbial culturing, biofilm reactor studies, nucleic acid extraction, nanopore sequencing, transcriptomics, proteomics, and single-cell genomics. Priya has also developed custom pipelines for omics data analysis, identified essential genes through comparative genomics, and engineered GFP-tagged bacterial strains to study biofilm dynamics. Beyond her research, she has demonstrated strong leadership by mentoring undergraduate and graduate students, teaching microbiology and bioinformatics courses, and assisting in grant writing. Her scholarly contributions include 14 peer-reviewed publications, two book chapters, and several conference presentations. With technical proficiency in advanced analytical tools such as GC-MS, HPLC, SEM, CLSM, and bioreactor operations, she combines wet-lab and computational approaches to address microbial corrosion and biofilm-associated challenges. Priya’s work reflects innovation, interdisciplinary collaboration, and a strong potential for advancing biotechnology and microbial engineering.

Profile: Google Scholar

Featured Publications

  • Sulfate-Reducing Bacteria: Unraveling Biofilm Complexity, Stress Adaptation, and Strategies for Corrosion Control – Science of the Total Environment

  • Comparative Transcriptomics Analysis of the Oleidesulfovibrio alaskensis G20 Biofilms Grown on Copper and Polycarbonate Surfaces – Biofilm

  • pH-dependent Genotypic and Phenotypic Variability in Oleidesulfovibrio alaskensis G20 – Applied and Environmental Microbiology

  • Impact of Graphene Layers on Genetic Expression and Regulation within Sulfate-Reducing Biofilms – Microorganisms

  • Influence of Copper on Oleidesulfovibrio alaskensis G20 Biofilm Formation – Microorganisms

Mr. Ebenezer Oni | Biochemistry | Best Researcher Award

Mr. Ebenezer Oni | Biochemistry | Best Researcher Award

Mr. Ebenezer Oni, Auburn University, United States

Ebenezer Ayomide Oni is an accomplished biochemist and molecular biology researcher with over five years of laboratory and teaching experience. He has contributed significantly to the fields of biochemical testing, molecular biology, and biophysical techniques, gaining recognition for his work in peer-reviewed journals. As a leader in scientific research, Oni has demonstrated expertise in protein purification, RNA/DNA analysis, and advanced data analysis techniques. He is dedicated to advancing scientific inquiry in biochemical and molecular research and is currently pursuing a PhD in Nutrition Sciences at Auburn University, Alabama.

Professional Profile

Orcid

Google Scholar

Evaluation of Ebenezer Ayomide Oni for the Research for Best Researcher Award

Summary of Suitability for the Award
Ebenezer Ayomide Oni demonstrates exceptional qualifications as a candidate for the Research for Best Researcher Award. With a robust academic background, including an ongoing PhD in Nutrition Sciences at Auburn University and a Master’s degree in Chemistry from the University of Alabama at Birmingham, Oni has consistently engaged in high-level scientific inquiry. His research spans critical areas such as molecular biology, biochemistry, and computational drug discovery, with a strong focus on addressing global health challenges such as diabetes and cancer.

Oni’s professional profile highlights significant achievements in both research and education. His experience as a Graduate Research Assistant showcases his ability to lead innovative projects, including studies on the mechanisms of nerve growth factor (NGF) in pancreatic β-cell function and survival. These investigations have important implications for diabetes treatment, positioning him as a researcher who contributes meaningfully to solving pressing medical problems. Additionally, his earlier work on RNA polymerase’s role in transcription fidelity and cancer development underscores his versatility and depth of knowledge in molecular biology.

🎓 Education

Ebenezer holds a PhD in Nutrition Sciences from Auburn University, Alabama, where he is exploring the role of nerve growth factors in pancreatic β-cell function, aiming to advance diabetes treatment. Previously, he earned a Master of Science in Chemistry from the University of Alabama at Birmingham, where he studied nucleotide incorporation mechanisms and cancer treatment. He completed his Bachelor of Science in Biochemistry at Adekunle Ajasin University in Nigeria, focusing on gene expression and diabetes research in fruit flies.

💼 Professional Experience

Ebenezer’s professional journey spans multiple prestigious institutions. He currently works as a Graduate Research Assistant at Auburn University, focusing on NGF’s role in β-cell survival. His previous roles include Research Assistant at the University of Alabama at Birmingham, where he led projects on RNA polymerase and cancer, and Associate Scientist at Adekunle Ajasin University, Nigeria, where he led drug discovery projects. He has also mentored undergraduates and presented research at international conferences.

🏅 Awards and Recognition

Ebenezer’s work has earned him recognition in scientific communities, including presenting at international conferences and publishing impactful research. His contributions to biochemical research, particularly in cancer and diabetes, have been widely acknowledged. As a mentor, he has helped guide junior researchers and students, contributing to their academic success. His efforts in drug discovery and molecular biology have reinforced his reputation as an emerging leader in biochemistry.

🌍 Research Skill On Biochemistry

Ebenezer has developed expertise in a range of biochemical techniques, including protein purification, RNA/DNA analysis, PCR, chromatography, and spectrophotometry. His research skillset also includes advanced data analysis tools such as GraphPad and SPSS. He is proficient in computer-aided drug design (CADD) and has a strong foundation in laboratory quality control and safety. His research aims to apply biochemistry techniques to better understand diseases and improve treatments, particularly for cancer and diabetes.

📖 Publication Top Notes

  • Title: Computational Evaluation of Bioactive Compounds from Colocasia affinis Schott as a Novel EGFR Inhibitor for Cancer Treatment
    Authors: TA Balogun, N Ipinloju, OT Abdullateef, SI Moses, DA Omoboyowa, …
    Citation: Cancer Informatics 20, 11769351211049244
    Year: 2021
  • Title: HIV/AIDS Epidemic and COVID-19 Pandemic in Africa
    Authors: AT Aborode, A Alexiou, S Ahmad, M Yasir Essar, OS Chibueze, …
    Citation: Frontiers in Genetics 12, 670511
    Year: 2021
  • Title: Molecular Interaction and Inhibitory Activity of Dandelion’s Compounds on Nucleoprotein: A Therapeutic Intervention in Lassa Fever
    Authors: B Kikiowo, EA Oni, O Iwaloye, O Kayode
    Citation: Biointerface Research in Applied Chemistry 11 (5), 12573-12583
    Year: 2021
  • Title: Demanding of Lassa Fever: Reducing Its Risk as an Infectious Disease
    Authors: AT Aborode, VA Adesewa, OE Ayomide, SO Olarenwaju
    Citation: Preprints
    Year: 2020
  • Title: Demanding of Lassa Fever: Reducing Its Risk as an Infectious Disease
    Authors: TA Abdullahi, VA Adesewa, EA Oni, SO Olarenwaju
    Citation: Preprints
    Year: 2020
  • Title: COVID-19 Pandemics: Effects and Prevention
    Authors: A Aborode, K Winner, OE Ayomide
    Citation: AIJR Preprints
    Year: 2020